Injectable Gamboge-Based In Situ Gel for Sustained Delivery of Imatinib Mesylate

The aim of this study was to prepare and characterize the imatinib mesylate (IM)-loaded gamboge-based ISG system for local administration of an anticancer agent against colorectal carcinoma. The ISG formulations were prepared in dimethyl sulfoxide (DMSO) and N-methyl-2-pyrrolidone (NMP). The physico...

Descripción completa

Detalles Bibliográficos
Autores principales: Jitrangsri, Kritamorn, Khaing, Ei Mon, Intaraphairot, Torsak, Phaechamud, Thawatchai, Mahadlek, Jongjan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10529659/
https://www.ncbi.nlm.nih.gov/pubmed/37754418
http://dx.doi.org/10.3390/gels9090737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10529659/
https://www.ncbi.nlm.nih.gov/pubmed/37754418
http://dx.doi.org/10.3390/gels9090737

Ejemplares similares